Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening and Intervention of Arteriosclerotic Cardiovascular Disease in Type 2 Diabetes in Zhejiang Province

NCT04866667 is registered in ClinicalTrials.gov with Zhejiang Provincial People's Hospital as lead sponsor.

NCT NCT04866667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04866667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening and Intervention of Arteriosclerotic Cardiovascular Disease in Type 2 Diabetes in Zhejiang Province
Lead sponsor
Zhejiang Provincial People's Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
May 31, 2024
Enrollment
316 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerotic cardiovascular disease, liraglutide, type 2 diabetes mellitus